Drug search by name

Dexmethylphenidate Extended-Release Capsules and Glaucoma

Result of checking the interaction of drug Dexmethylphenidate Extended-Release Capsules and disease Glaucoma for safety when used together.

Check result:

Dexmethylphenidate Extended-Release Capsules <> Glaucoma

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of most CNS stimulants is contraindicated in patients with glaucoma, as these agents exhibit sympathomimetic activity and may induce mydriasis provoking an increase in intraocular pressure.

References:

"Product Information. Focalin (dexmethylphenidate)." Mikart Inc, Atlanta, GA.
"Product Information. Ritalin (methylphenidate)." Novartis Pharmaceuticals, East Hanover, NJ.

Dexmethylphenidate Extended-Release Capsules

Generic Name: dexmethylphenidate

Brand Name: Focalin, Focalin XR

Synonyms: Dexmethylphenidate

What is Dexmethylphenidate Extended-Release Capsules?